Omeros Corporation (OMER) DCF Valuation

Omeros Corporation (OMER) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Omeros Corporation (OMER) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Engineered for accuracy, our Omeros Corporation (OMER) DCF Calculator enables you to assess Omeros Corporation's valuation using real-world financial data, offering complete flexibility to modify all essential parameters for enhanced projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 111.8 73.8 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 -33.98 -100 0 0 -33.5 -33.5 -33.5 -33.5 -33.5
EBITDA -144.2 -168.0 -172.2 -162.4 -163.6 .0 .0 .0 .0 .0
EBITDA, % -129.02 -227.63 100 100 100 20 20 20 20 20
Depreciation 1.8 1.6 1.4 1.0 .9 .0 .0 .0 .0 .0
Depreciation, % 1.6 2.19 100 100 100 60.76 60.76 60.76 60.76 60.76
EBIT -146.0 -169.6 -173.6 -163.4 -164.5 .0 .0 .0 .0 .0
EBIT, % -130.62 -229.82 100 100 100 20 20 20 20 20
Total Cash 60.8 135.0 157.3 194.9 171.8 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 35.2 3.8 82.5 242.0 6.7
Account Receivables, % 31.47 5.2 100 100 100
Inventories 48.3 114.5 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 43.19 155.19 100 100 100 88.64 88.64 88.64 88.64 88.64
Accounts Payable 5.3 4.2 13.4 6.0 7.7 .0 .0 .0 .0 .0
Accounts Payable, % 4.77 5.69 100 100 100 62.09 62.09 62.09 62.09 62.09
Capital Expenditure -.3 -.3 -.3 -.1 -.4 .0 .0 .0 .0 .0
Capital Expenditure, % -0.29873 -0.3834 100 100 100 -0.13643 -0.13643 -0.13643 -0.13643 -0.13643
Tax Rate, % 32.65 32.65 32.65 32.65 32.65 32.65 32.65 32.65 32.65 32.65
EBITAT -184.8 -156.1 176.1 25.8 -110.8 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -261.5 -190.8 222.3 -140.3 126.7 -1.0 .0 .0 .0 .0
WACC, % 9.11 9 7.64 7.64 8.63 8.41 8.41 8.41 8.41 8.41
PV UFCF
SUM PV UFCF -.9
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt 354
Equity Value -355
Diluted Shares Outstanding, MM 63
Equity Value Per Share -5.66

What You Will Get

  • Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: Omeros Corporation’s (OMER) financial data pre-filled to kickstart your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A sleek Excel model that can be tailored to fit your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.

Key Features

  • Comprehensive Financial Data: Omeros Corporation's historical financial statements and pre-filled projections.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Calculations: Monitor Omeros Corporation's intrinsic value updates instantly.
  • Intuitive Visual Outputs: Dashboard charts showcase valuation results and essential metrics.
  • Designed for Precision: A professional-grade tool for analysts, investors, and finance professionals.

How It Works

  • Step 1: Download the prebuilt Excel template featuring Omeros Corporation’s (OMER) data.
  • Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see the recalculated results, including Omeros Corporation’s intrinsic value.
  • Step 5: Utilize the outputs to make informed investment decisions or generate comprehensive reports.

Why Choose This Calculator for Omeros Corporation (OMER)?

  • Accurate Data: Up-to-date Omeros financials provide dependable valuation outcomes.
  • Customizable: Tailor essential factors like growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Built-in calculations remove the hassle of starting from the ground up.
  • Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: Simple design and guided instructions make it accessible for all users.

Who Should Use Omeros Corporation (OMER)?

  • Investors: Gain insights and make informed decisions with our comprehensive analysis tools.
  • Pharmaceutical Analysts: Streamline your research with our detailed reports on drug development and market potential.
  • Healthcare Consultants: Easily customize our data for client presentations or strategic recommendations.
  • Biotech Enthusiasts: Enhance your knowledge of the biotech sector through in-depth case studies and examples.
  • Educators and Students: Utilize our resources as a hands-on learning tool in life sciences and finance courses.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Omeros Corporation (OMER) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Omeros Corporation (OMER).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

No products were found matching.